GLENMARKNSEGlenmark Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Fri, 8 Aug · 16:13 IST

Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Glenmark Pharmaceuticals has informed the stock exchanges that it will hold an earnings call to discuss its Q1 FY 2025-26 results. The call is scheduled for Monday, August 18, 2025, from 8:30 AM to 9:30 AM IST. Dial-in numbers have been provided for participants in India, USA, UK, Singapore, and Hong Kong. The recording of the call will be made available on the company's website within 24 hours of the call. Investors can pre-register online or contact Utkarsh Gandhi for any clarifications.

Likely market impact

This is a routine advance notice of the quarterly results call. The actual Q1 FY26 numbers and management commentary on August 18 will be the key catalyst that could move the stock. No direct price impact is expected from this scheduling announcement alone.